Zhenluan Tian - Publications, H-index & Citations

Zhenluan Tian

Sun Yat-sen Memorial Hospital

6H指数

29论文数

461被引数

收录论文 9

发表时间

Efficacy, safety, and biomarker analysis of neoadjuvant camrelizumab plus apatinib as a chemotherapy-free strategy for early-stage triple-negative breast cancer: a phase II study 新辅助卡瑞利珠单抗联合阿帕替尼作为无化疗策略治疗早期三阴性乳腺癌的疗效、安全性及生物标志物分析：一项II期研究

Breast Cancer Research and Treatment

IF3

2026-08-31

PREAI

Zhenluan Tian; Hengyu Li; Yuxin Deng; Herui Yao; Ying Wang; Liang Jin; Heran Deng; Na Chen; Jieqiong Liu

Unsupervised and supervised machine learning to identify variability of tumor-educated platelets and association with pan-cancer: A cross-national study

Fundamental Research

IF6.3

2023-11-02

OAAI

Xiong Chen; Runnan Shen; Lin Lv; Dongxi Zhu; Guochang You; Zhenluan Tian; Jinwei Chen; Shen Lin; Jiatang Xu; Guibin Hong; Hu Li; Mingli Luo; Lin Cao; Shaoxu Wu; Kai Huang

Single-cell Analysis of KN026 in Combination with KN046 in Treating Patients with Advanced HER2-positive Breast Cancer

CANCER RESEARCH

IF16.6

2023-03-01

PREAI

Liu, Jieqiong; Liao, Jianyou; Tian, Zhenluan; Wang, Jien; Song, Chuangui

Multicenter phase II trial of Camrelizumab combined with Apatinib and Eribulin in heavily pretreated patients with advanced triple-negative breast cancer

NATURE COMMUNICATIONS

IF15.7

2022-05-31

OAAI

Liu, Jieqiong; Wang, Ying; Tian, Zhenluan; Lin, Ying; Li, Hengyu; Zhu, Zhaowen; Liu, Qiang; Su, Shicheng; Zeng, Yinduo; Jia, Weijuan; Yang, Yaping; Xu, Shengqiang; Yao, Herui; Jiang, Wen; Song, Erwei

Preliminary safety and efficacy results of camrelizumab in combination with apatinib and eribulin in heavily pretreated patients with advanced triple-negative breast cancer: A phase II trial

CANCER RESEARCH

IF16.6

2022-02-15

PREAI

Liu, Jieqiong; Tian, Zhenluan; Wang, Ying; Lin, Ying; Li, Hengyu

Prognostic and predictive value of the combination of TOP2A and HER2 in node-negative tumors 2 cm or smaller (T1N0) breast cancer

BREAST CANCER

IF2.9

2020-08-11

PREAI

Zhong, Wenjing; Yang, Yaping; Zhang, Ailing; Lin, Wanyi; Liang, Gehao; Ling, Yun; Zhong, Jiajie; Yong, Juanjuan; Liu, Zihao; Tian, Zhenluan; Lin, Qun; Luo, Qing; Li, Yangyang; Gong, Chang

Autophagy-associated circRNA circCDYL augments autophagy and promotes breast cancer progression 自噬相关circRNA circCDYL增强自噬并促进乳腺癌进展

MOLECULAR CANCER

IF33.9

2020-03-25

172

OAAI

Liang, Gehao; Ling, Yun; Mehrpour, Maryam; Saw, Phei Er; Liu, Zihao; Tan, Weige; Tian, Zhenluan; Zhong, Wenjing; Lin, Wanyi; Luo, Qing; Lin, Qun; Li, Qiufang; Zhou, You; Hamai, Ahmed; Codogno, Patrice; Li, Jun; Song, Erwei; Gong, Chang

circHEACA promotes anti-HER2 drug resistance by HEACA-GRB7/AKT axis in HER2+breast cancer patients

CANCER RESEARCH

IF16.6

2020-02-15

PREAI

Ling, Yun; Liang Gehao; Liu, Zihao; Tian, Zhenluan; Zhong, Wenjing; Lin, Wanyi; Chang, Gong

Autophagy-associated circRNA AUACA1 mediates the proliferation of breast cancer cells via a miR-1275/ATG7/autophagic flux axis

CANCER RESEARCH

IF16.6

2019-07-01

PREAI

Liang, Gehao; Ling, Yun; Liu, Zihao; Mehrpour, Maryam; Hamai, Ahmed; Tian, Zhenluan; Tan, Luyuan; Zhong, Wenjing; Lin, Wanyi; Codogno, Patrice; Song, Erwei; Gong, Chang

研究方向